Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Madison Clague"'
Autor:
Carla Y. Kim, Zomer Sardar, Biniyam A. Ayele, Shannon Fleck‐Derderian, Catherine E. Barrett, Yifei Sun, Madison Clague, Holly A. Hurst, Abhilasha Boruah, Jason Zucker, Ryan Maddox, James Sejvar, Kiran T. Thakur
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 10, Iss 8, Pp 1433-1441 (2023)
Abstract Objective Emerging variants and sublineages of SARS‐CoV‐2 have differing disease severity, transmissibility, and immune evasion. The neurological conditions associated with the original strain of SARS‐CoV‐2 are well established. Our
Externí odkaz:
https://doaj.org/article/343bd9a22235444f8fb5087f8bdca1f4
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 12 (2019)
Background: There are few treatment options for multiple sclerosis (MS) patients with advanced disability [expanded disability status scale (EDSS) ⩾ 6.0]. In 2010, we reported initial results of using intrathecal methotrexate (ITMTX) in patients wi
Externí odkaz:
https://doaj.org/article/9dd055bd2a8f449f97b5dcb2b273b8ee
Autor:
Carla Y. Kim, Emily N. McNeill, Casey Young, Fredrick King, Madison Clague, Marissa Caldwell, Abhilasha Boruah, Jason Zucker, Kiran T. Thakur
Publikováno v:
Neurology: Clinical Practice. 13:e200166
Background and ObjectivesThe global spread of the COVID-19 pandemic accelerated the vaccine development time line, regulatory approval, and widespread implementation in the population underscoring the importance of postauthorization/postlicensure vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74d9e9ec08a85ec53ae25d8287dd8e18
https://doi.org/10.1212/cpj.0000000000200166
https://doi.org/10.1212/cpj.0000000000200166
Autor:
Madison Clague, Carla Kim, Jason Zucker, Daniel A Green, Yifei Sun, Susan Whittier, Kiran T Thakur
Publikováno v:
Open forum infectious diseases. 9(8)
Background Herpes simplex virus–1 is the most common cause of sporadic encephalitis worldwide and requires prompt antiviral treatment. Traditionally, herpes simplex virus–1 (HSV-1) cerebrospinal fluid (CSF) testing is conducted using standalone p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae069ec6bc77b96e5ce174b94a060bc7
https://pubmed.ncbi.nlm.nih.gov/35937646
https://pubmed.ncbi.nlm.nih.gov/35937646
Publikováno v:
Therapeutic Advances in Neurological Disorders
Therapeutic Advances in Neurological Disorders, Vol 12 (2019)
Therapeutic Advances in Neurological Disorders, Vol 12 (2019)
Background: There are few treatment options for multiple sclerosis (MS) patients with advanced disability [expanded disability status scale (EDSS) ⩾ 6.0]. In 2010, we reported initial results of using intrathecal methotrexate (ITMTX) in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a84ee62040d01a2d4a4706df188fbc5f
https://doi.org/10.1177/1756286419892360
https://doi.org/10.1177/1756286419892360